Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA funny taste in the mouth is a recognised side effect of Mounjaro (tirzepatide). It tends to appear early in treatment, most often in the first few weeks or after a dose increase, and usually settles on its own as your body adjusts. It is not a sign that something has gone seriously wrong, but it is worth understanding why it happens and what, if anything, you should do about it. Mounjaro is a prescription-only medicine; a prescriber assesses whether it is clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is that tirzepatide slows gastric emptying — food and stomach acid move through your digestive system more gradually than usual. That slower transit can alter the chemical signals that reach the taste receptors on your tongue and the back of your palate, producing a metallic, bitter, or generally off flavour that feels hard to place. If you want more detail on how tirzepatide works at the receptor level, the tirzepatide overview on this site covers the dual GIP and GLP-1 mechanism clearly.
There is a secondary factor too. Nausea, which is the most common GI side effect of Mounjaro, frequently travels with taste changes. When your stomach is unsettled, saliva composition shifts slightly, and that alone can make food taste flat, metallic, or sour. The two symptoms are cousins rather than coincidences. The NHS tirzepatide medicines page lists taste disturbance among the side effects patients may notice, which confirms this is a documented pattern rather than an individual quirk.
A third possibility, less common, is that the taste sensation originates partly in the mouth itself. GLP-1 receptors are present in salivary gland tissue, and activating them may subtly alter saliva flow and composition — enough for some people to notice a persistent background taste even when they are not feeling sick. If you would like a closer look at exactly what that experience involves and why it happens, our page on Mounjaro taste in mouth covers the topic in more detail. This is thought to be more common in the early weeks, when the medicine is newest to your system.
Most people who report a funny taste on Mounjaro notice it in one of two windows: the first two to four weeks of treatment, or the few days after moving to a higher dose. Both are times when tirzepatide's effects on your gut are sharpest. The symptom tends to peak around 24 to 48 hours after an injection, which is roughly when the medicine's plasma concentration is highest, then fades as the week progresses.
For many people, it resolves within a fortnight of starting or dose-stepping, as the digestive system finds its new rhythm. A smaller number find it lingers at a low level for the duration of treatment, though usually without being disruptive enough to stop eating normally. If the taste has not improved after four to six weeks at a stable dose, that is a reasonable point to raise with your prescriber, not because it signals danger, but because there may be practical adjustments worth discussing.
You can read about related mouth-based experiences, including why some people notice a coating or dryness on the tongue, on the Mounjaro and the tongue page, or explore how the broader pattern of oral side effects presents in the Mounjaro mouth symptoms guide.
None of the following replaces advice from your prescriber, but they reflect what patients commonly find useful and are consistent with general hydration and oral hygiene guidance.
Drinking enough water throughout the day is the single most effective step. Dry mouth amplifies taste disturbance; keeping saliva flowing dilutes any lingering chemical aftertaste from the medicine. Some people find cold or room-temperature water more tolerable than hot drinks during the first weeks, when nausea is also present. A question that comes up in our pharmacy is whether brushing teeth more often helps, the answer seems to be yes for some people, particularly before meals, because a clean oral environment reduces the chance of taste interference stacking on top of the medicine's effect.
Eating smaller meals and choosing plainer, lower-fat foods during the adjustment period also reduces the overall GI load, which in turn lessens nausea-linked taste changes. Protein-rich, mild-flavoured foods (eggs, plain chicken, oats) seem to sit better with many Mounjaro users than heavily spiced or very sweet options. Zinc deficiency can independently cause taste changes, so if your diet has been very restricted, mentioning this to your prescriber is worth doing.
The Mounjaro treatment guide has a broader look at managing the early adjustment period alongside all the common side effects, not just taste.
Most funny tastes on Mounjaro are inconvenient rather than medically significant. The situations where you should get advice sooner are: a taste change accompanied by mouth sores, pain on swallowing, or visible changes to the tongue or gum tissue; any taste disturbance that makes it genuinely impossible to eat or drink enough to stay hydrated; or a sudden change in taste alongside severe stomach pain that radiates to the back, which could indicate pancreatitis and requires urgent medical attention. The MHRA highlighted acute pancreatitis as a known but infrequent risk of GLP-1 medicines in its January 2026 Drug Safety Update, it is rare, but the symptom pattern is important to know.
If you have a more general question about whether Mounjaro is appropriate for your situation, or if you are partway through treatment and the side effects feel hard to manage, our prescribers are available seven days a week. You can also read about how treatment costs are structured on the Mounjaro pricing page before deciding whether to proceed. If you are ready to explore whether Mounjaro could be right for you, check your eligibility with a free consultation and a real clinician will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.